Immunic Therapeutics has closed a private placement that could provide up to $400 million to support the company’s Phase 3 clinical program of vidofludimus calcium in multiple sclerosis (MS) and help fund its transition into a commercial-stage company as it prepares for potential regulatory approval of the oral therapy. The financing will support completion of…
Self-Connection
By Angel Blair When we hear the word relationships we often think about the connections we have to others. Bonds with our family, friends, significant others, etc. So we tend to forget one of the most important but commonly overlooked relationships … Continue reading → Source: blog.mymsaa.org
Natalizumab under the skin saves time (makes money)
Tweet Saving time and money is the usual saying and is the mantra for NICE. saving time means lower staff costs and saves money..For pharma by the NHS saving time they make more money. Why because their more expensive patented compound is used over cheaper genetics consuming more staff time. As patents run out pharma…
Re-set or Re-tune are B cell therapies going to do it.
Tweet This is a review article and it gives some views on targeting a cure. There is alot of hope on CAR-T therapy of B cells, but is it anybetter than B cell depletion. This paper doesnt give that answer but perhaps you could try and answer it with available technology. Maybe if they could…
MS Canada raising money, support with this year’s Read-a-Thon for kids
MS Canada is hosting its annual MS Read-a-Thon, a fundraiser encouraging children to turn their reading goals into donations to support people with multiple sclerosis (MS). This year’s event aims to raise CA$65,000 (nearly $48,000) to support MS research and community programs. So far, 565 people have registered, and more than CA$29,000 (more than $20,000) has been raised….
I’m grateful for the days when MS is simply background noise
When I was diagnosed with relapsing-remitting multiple sclerosis (MS) at 16, it was loud. My symptoms were significant; the fatigue ended my athletic drive, the searing nerve pain left me grinding my teeth constantly, and I experienced a period of being legally blind. MS didn’t politely wait its turn or subtly clear its throat to…
Certain diets may help reduce inflammation in MS, new review finds
Following specific diets may help reduce inflammation in people with multiple sclerosis (MS), but more research is needed, according to a new review paper. Researchers analyzed data from 13 randomized clinical trials and found some evidence that certain diets, including modified Mediterranean-style and Paleolithic diets, were linked to lower levels of a key inflammation marker…
Killer immune cells targeting Epstein-Barr virus may help drive MS
A type of immune cell that has received little attention in multiple sclerosis (MS) research may play a key role in driving the disease. A study found that some people with MS had abnormally high levels of virus-fighting CD8 T-cells in the fluid surrounding the brain and spinal cord. Many of these cells were primed…
EBV variants and response to interferons
Tweet The are some people that believe that MS is caused by EBV and there are some of then that think there are EBVvariants that cause MS. Now i can buy the former view but as to the latter view I say where is the evidence, you just have to read to see that people…
Cladribine inhibits CNS inflammation…NSS!
Tweet Cladribine enters the CNS and about 25% of the levels in the blood reach the brain and so active levels of cladribine can enter the CNS. In this study they say “Regarding OCBs status, OCBs disappeared in five patients while they were detected in two patients (A total of 39 gave repeat samples) who…